Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

BUILDING A BUSINESS

So you want to start a biotech company

Nature Biotechnology volume 40, pages 296–300 (2022)Cite this article

Commercializing research is fraught with pitfalls, but a thoughtful checklist can ensure you set off on the right path and give your fledgling business the best chance of success.

These days, it feels as though more and more academics are venturing into the dynamic and fast-paced world of life-science startups. Many US academic institutions now provide access to training programs for academic founders. But taking the plunge into the realm of business, finance and law can nevertheless be a daunting process. A new startup founder faces numerous (often unforeseen) obstacles when seeking to commercialize their research. This article lays out those critical issues and provides some helpful tips for faculty members seeking to commercialize their research.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: A bioentrepreneur’s to-do list.

References

  1. Harroch, R. 12 tips for naming your startup business. Forbes https://www.forbes.com/sites/allbusiness/2016/10/23/12-tips-for-naming-your-startup-business/?sh=4c2507b1904e (2016).

  2. Ford, D. & Nelsen, B. Nat. Biotechnol. 32, 15–23 (2014).

    Article  CAS  Google Scholar 

  3. Ford, D. & Kohlbrenner, W. Nat. Biotechnol. 34, 226–230 (2016).

    Article  CAS  Google Scholar 

  4. Beylin, D., Chrisman, C. & Weingarten, M. Bioentrepreneur https://doi.org/10.1038/bioe.2011.5 (2011).

  5. Seibel, M. How to split equity among co-founders. Y Combinator https://www.ycombinator.com/library/5x-how-to-split-equity-among-co-founders (accessed 1 February 2022).

  6. Wasserman, N. & Hellman, T. The very first mistake most startup founders make. Harv. Bus. Rev. https://hbr.org/2016/02/the-very-first-mistake-most-startup-founders-make (2016).

  7. University Lab Partners. Funding options for biotech startups. University Lab Partners blog https://www.universitylabpartners.org/blog/funding-options-for-biotech-startups (2021).

  8. Murphey, R. Top biotech venture capital funds of 2018–2021. BayBridge Bio https://www.baybridgebio.com/blog/top_vcs_2018.html (2021).

  9. Henderson, B. Guide: how to approach life sciences fundraising. Brex https://www.brex.com/blog/approaching-life-sciences-fundraising/ (2020).

  10. Moran, N. Nat. Biotechnol. 35, 299–300 (2017).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Technology Operations and Ventures, NYU Langone Health, New York, NY, USA

    Sadhana Chitale

  2. Mass General Brigham, Boston, MA, USA

    Colm Lawler

  3. Goldilocks Therapeutics Inc, Bedford, NY, USA

    Arthur Klausner

Authors
  1. Sadhana Chitale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Colm Lawler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arthur Klausner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sadhana Chitale.

Ethics declarations

Competing interests

The authors declare no competing interests.

Supplementary Information

Supplementary Information

Supplementary Glossary.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chitale, S., Lawler, C. & Klausner, A. So you want to start a biotech company. Nat Biotechnol 40, 296–300 (2022). https://doi.org/10.1038/s41587-022-01239-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-022-01239-9

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing